Examining the impact of green spaces on heart health in Louisville

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how environmental factors, particularly the presence of green spaces, influence the health of residents in Louisville, focusing on cardiovascular diseases and metabolic health. By assessing changes in neighborhood characteristics, the study aims to understand their effects on heart health, disease risk factors, and overall community well-being. Participants will engage in interventions that promote greenness as a therapeutic approach to improve health outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 30-70 years of age.
* Live within the targeted study location

Exclusion Criteria:

* Unwilling or unable to provide consent.
* HIV/AIDS, active treatment for cancer, active bleeding including wounds.
* Body weight less than 100 pounds or BMI\>40.
* Prisoners and other vulnerable populations.
* Anyone that PI thinks is unsafe to participate in study.

Where it's running

• University of Louisville
  Louisville, Kentucky, United States Recruiting

Study contacts

• Principal investigator: Rachel Keith, PhD — University of Louisville
• Study coordinator: Jackie Research Coordinator, MS
• Email: jacqueline.gallagher@louisville.edu
• Phone: 502-852-6167

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• Bringing preventive cardiovascular care to Indigenous and remote communities

  This project tests a mobile health unit to screen and provide culturally safe cardiovascular and metabolic care for Indigenous and remote communities in Canada.

  Recruiting Laval University · Québec, Quebec · NCT07869069

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.